retatrutide class for weight loss: Study shows 30% body weight loss Retatrutide Before and After: Doctor

The numbers tell the story: roughly 6% of Americans (20 million people) were taking GLP-1 drugs by late 2025 , with half using them specifically for weight loss a 600% increase in obesity use over just six years

These changes can be just as important as weight loss, especially during maintenance phases

PlexusDx offers multiple GLP-1 options including oral semaglutide, compounded tirzepatide injection, oral tirzepatide, and the GLP-Squared dual compound

There is a need to identify who is at highest fracture risk among patients starting a GLP1-Ra

They may also affect: Insulin sensitivity Fat distribution Muscle mass Appetite and satiety signals Sleep quality Stress response As estrogen declines, the body tends to store more visceral fat even if caloric intake remains the same

Zepbound, which was first approved for weight management in November 2023, now offers new hope for those with obesity and obstructive sleep apnea, Eli Lilly reported